Pap Smear Research Study
Not Applicable
Completed
- Conditions
- Cervical Cancer
- Registration Number
- NCT00743626
- Lead Sponsor
- University Health Network, Toronto
- Brief Summary
The principal hypothesis of this study is that HPV testing and/or p16 testing, either alone or in combination or associated with a Pap smear, will demonstrate greater specificity for clinically significant precancerous disease than will a Pap smear alone and that these tests will be of comparable or superior sensitivity than the Pap smear.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 1712
Inclusion Criteria
- 18 years and older
- Ability to speak and clearly understand English
- Female patients
Exclusion Criteria
- No previous history of Cervical Cancer Treatment(LEEP,Laser,Cone etc.)
- Women who have had Pap smears within the previous 10 months
- Women under the age of 18.
- Women who are pregnant.
- Inability to give informed consent in English
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method To provide cervical cancer screening (Pap smear, HPV test and/or p16 tests) to determine whether further intervention (colposcopy) is required 1st visit, 12 months, 18 months follow up
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Health Network - Toronto Western Hospital
🇨🇦Toronto, Ontario, Canada
University Health Network - Toronto Western Hospital🇨🇦Toronto, Ontario, Canada